Patent Assignment
Reel/Frame 030236/0267
Assignment of Assignor's Interest
Recorded: 2013-04-17
Pages: 8
Assignor
ARCION THERAPEUTICS, INC.
Executed: 2010-11-05
Assignee
VALLINEX, INC.
2400 BOSTON STREET, SUITE 330, BALTIMORE, MARYLAND, 21224
Covered Property
(1)
Injectable Resiniferatoxin
Application:
13/862,260 →
Publication:
US 2013/0303620
Related Assignments
(7)
Other recorded transfers of the patent in this record — the chain of ownership.
Assignment of Assignor's Interest
Apr 17, 2013
From: BURCH, RONALD M.; CARTER, RICHARD B.; LAZAR, JEFFREY D.
To: ALGORX PHARMACEUTICALS, INC.
Reel/Frame 030236/0217 →
Assignment of Assignor's Interest
Apr 17, 2013
From: ALGORX PHARMACEUTICALS, INC.; ANESIVA INC.
To: ARCION THERAPEUTICS, INC.
Reel/Frame 030236/0225 →
Merger
Feb 26, 2014
From: VALLINEX, INC.
To: CENTREXION I, INC., C/O CENTREXION CORPORATION
Reel/Frame 032302/0737 →
Corrective Assignment to Correct the Assignee Previously Recorded at Reel: 032302 Frame: 0737. Assignor(S) Hereby Confirms the Merger.
May 20, 2014
From: VALLINEX, INC.
To: CENTREXION I, INC.
Reel/Frame 032937/0699 →
Assignment of Assignor's Interest
Apr 6, 2016
From: CENTREXION I, INC.
To: CENTREXION THERAPEUTICS CORPORATION
Reel/Frame 038207/0784 →
Security Interest
Jul 12, 2023
From: CENTREXION THERAPEUTICS CORPORATION
To: AVENUE VENTURE OPPORTUNITIES FUND, L.P., AS AGENT
Reel/Frame 064256/0125 →
Release of Security Interest
Nov 21, 2025
From: AVENUE VENTURE OPPORTUNITIES FUND, L.P., AS AGENT
To: CENTREXION THERAPEUTICS CORPORATION
Reel/Frame 073683/0099 →